Subscribe
sebra-shutterstock-com-court-gavel--1
9 January 2017Americas

Sanofi and Regeneron to appeal against Praluent injunction

Sanofi and Regeneron Pharmaceuticals have revealed plans to appeal against an injunction granted to Amgen, which prevents the companies from selling cholesterol-lowering medicine Praluent (alirocumab).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Sanofi and Regeneron’s appeal to suspend Amgen injunction denied
12 January 2017   A US District Court has denied Sanofi and Regeneron’s motion to suspend an injunction which was obtained by Amgen earlier this month.
Americas
Amgen wins injunction in Sanofi Repatha suit
6 January 2017   Sanofi and Regeneron Pharmaceuticals must stop selling cholesterol-lowering medicine Praluent after Amgen obtained an injunction against the companies.
Americas
Amgen secures patent win in Repatha case
4 January 2017   Amgen secured victory yesterday as a US federal judge refused to throw out a ruling upholding the validity of two patents owned by the company.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
Sanofi and Regeneron’s appeal to suspend Amgen injunction denied
12 January 2017   A US District Court has denied Sanofi and Regeneron’s motion to suspend an injunction which was obtained by Amgen earlier this month.
Americas
Amgen wins injunction in Sanofi Repatha suit
6 January 2017   Sanofi and Regeneron Pharmaceuticals must stop selling cholesterol-lowering medicine Praluent after Amgen obtained an injunction against the companies.
Americas
Amgen secures patent win in Repatha case
4 January 2017   Amgen secured victory yesterday as a US federal judge refused to throw out a ruling upholding the validity of two patents owned by the company.

More on this story

Americas
Sanofi and Regeneron’s appeal to suspend Amgen injunction denied
12 January 2017   A US District Court has denied Sanofi and Regeneron’s motion to suspend an injunction which was obtained by Amgen earlier this month.
Americas
Amgen wins injunction in Sanofi Repatha suit
6 January 2017   Sanofi and Regeneron Pharmaceuticals must stop selling cholesterol-lowering medicine Praluent after Amgen obtained an injunction against the companies.
Americas
Amgen secures patent win in Repatha case
4 January 2017   Amgen secured victory yesterday as a US federal judge refused to throw out a ruling upholding the validity of two patents owned by the company.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler